Clinical trials
Observational Hemorrhage trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
98 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 2 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 8 |
| 2015 | 5 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 9 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Recruiting | 11 |
| Terminated | 8 |
| Active, not recruiting | 7 |
| Unknown status | 7 |
| Enrolling by invitation | 4 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HemoSonics LLC | 4 |
| University of California, San Francisco | 4 |
| University of Maryland, Baltimore | 4 |
| Boston Children's Hospital | 3 |
| Johns Hopkins University | 3 |
| Stanford University | 3 |
| Abbott Medical Devices | 2 |
| Karolinska Institutet | 2 |
| Mayo Clinic | 2 |
| University of Cincinnati | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemorrhage | 98 |
| Thrombosis | 16 |
| Hemostatic Disorders | 10 |
| Stroke | 9 |
| Atrial Fibrillation | 7 |
| Cerebral Hemorrhage | 5 |
| Hemophilia A | 5 |
| Heart Failure | 4 |
| Coronary Artery Disease | 3 |
| Hemorrhoids | 3 |
Trials
Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.